US2021033889A1PendingUtilityA1

High plus treatment zone lens design and method for preventing and/or slowing myopia progression

Assignee: JOHNSON & JOHNSON VISION CAREPriority: Aug 20, 2014Filed: Oct 20, 2020Published: Feb 4, 2021
Est. expiryAug 20, 2034(~8.1 yrs left)· nominal 20-yr term from priority
G02C 7/04A61F 2/145G02C 7/044G02C 2202/24A61F 9/00G02C 7/041A61F 2/1618G02C 7/066A61F 2/142G02C 7/048A61F 2/16G02C 7/06
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Contact lenses incorporate high plus or add power profiles that at least one of slow, retard or preventing myopia progression and minimize halo effect. The lens includes a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile that increases from an outer margin of the center zone to a positive power within the at least one treatment zone of greater than +5.00D.

Claims

exact text as granted — not AI-modified
1 . An ophthalmic lens for at least one of slowing, retarding or preventing myopia progression in a patient, the ophthalmic lens comprising:
 a treatment zone with a negative dioptric power adapted to correct myopic vision of said patient; and   at least one enhanced treatment zone having an ADD power relative to said negative dioptric power of said treatment zone, wherein said ADD power is between +5D and +15D,   wherein the at least one enhanced treatment zone is positioned at a center of said ophthalmic lens and extends to a radius of about 0.7 mm from said center.   
     
     
         2 . The ophthalmic lens according to  claim 1 , wherein the ADD power within said enhanced treatment zone is between +10D and +15D. 
     
     
         3 . The ophthalmic lens according to  claim 1 , wherein the ADD power within said enhanced treatment zone is a stepped increase in add power. 
     
     
         4 . The ophthalmic lens according to claim  22 , further comprising a second enhanced treatment zone having an ADD power relative to said negative dioptric power of said treatment zone. 
     
     
         5 . The ophthalmic lens according to  claim 4 , wherein said enhanced treatment zone has a radius of 0.75 mm. 
     
     
         6 . An ophthalmic lens for at least one of slowing, retarding or preventing myopia progression in a patient, the ophthalmic lens comprising:
 a first zone having zero dioptric power; and   at least one enhanced treatment zone having an ADD power relative to said zero dioptric power of said first zone, wherein said ADD power is between +5D and +15D,   wherein the at least one enhanced treatment zone is positioned at a center of said ophthalmic lens and extends to a radius of about 0.7 mm from said center.   
     
     
         7 . The ophthalmic lens according to  claim 6 , wherein the ADD power within said enhanced treatment zone is between +10D and +15D. 
     
     
         8 . The ophthalmic lens according to  claim 6 , wherein the ADD power within said enhanced treatment zone is a stepped increase in add power. 
     
     
         9 . The ophthalmic lens according to  claim 6 , further comprising a second enhanced treatment zone having an ADD power relative to said zero dioptric power of said treatment zone. 
     
     
         10 . The ophthalmic lens according to  claim 9 , wherein said enhanced treatment zone has a radius of 0.75 mm.

Join the waitlist — get patent alerts

Track US2021033889A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.